Market Research Blog

According to a recent Future Market Insights (FMI) industry analysis, the demand in the high-end cellomics market is expected to top US$ 288.8 Mn in 2021, growing at a CAGR of 6.4% during the forecast period 2021-2031.

High-end cellomics is a process that is utilized in drug discovery and biological research to identify substances such as small molecules, RNAi or peptides which alter the phenotype of a cell in a wanted manner.

The global high-end cellomics market is primarily driven by increasing technological advancement in imaging solutions. Technological advancements such as the usage of polarization methods, multicolored fluorescence-based reagents, automated imaging technology, and flow cytometry are also anticipated to boost the market growth further.

Increasing investment in research and development in cellular science of novel molecules by private and government organizations, technological advancement in imaging solutions, and advantages related to these innovations such as improved scope for pplication in gene documentation & neonatal development learning will drive the high-end cellomics market.

Key Takeaways from High-end Cellomics Market Study

• The global high-end cellomics market is expected to reach US$ 536.9 Mn by 2031.
• By application, drug discovery accounted for 55.5% of overall sales in 2021 and is expected to continue to grow at the same trend during the forecast period.
• By end-users, pharmaceutical and biotechnology companies will account for the largest share of 51.8% during the forecast period.
• By region, North America held the largest share of 32.7% of the global high-end cellomics market.
• By country, the U.S. is the most lucrative market in the global high-end cellomics market with US$ 81.7 Mn revenue in 2021.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-14164

Who is Winning?

Some of the leading manufacturers of high-end cellomics are focusing on product approvals and launch strategies for global expansion objectives, thereby, enhancing their market presence. The leading key players are focusing on strategic alliance to expand the product offerings.

Yokogawa Electronic Corporation in December 2020, agreed with InSphero AG to jointly promote the use of Yokogawa’s high-end cellomics systems for drug discovery research which actively involves the use of 3D in vitro models.

The key market players covered by FMI include PerkinElmer, Inc., ThermoFisher Scientific, Inc., Molecular Devices LLC (part of Danaher Corporation) and Yokogawa Electric Corporation.

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

High-end Cellomics Market by Category

Application:

• Academic Research/Basic Research
• Drug Discovery
  • Primary & Secondary Screening
  • Target Identification & Validation
  • Invitro Toxicity Studies
  • Compound Profiling

End-User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Independent Contract Research Organizations (CROs)

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-14164

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion & Exclusion

3. Key Trends

3.1. Key Trends Impacting the Market

3.2. Trends in Diverse Application

4. Key Success Factors

4.1. Key Products USP Analysis

4.2. Key Manufacturers Promotional Strategies

4.3. Value Chain Analysis

4.4. PESTLE Analysis

4.5. PORTERS Analysis

4.6. Key Regulations

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-14164

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a latest study by Future Market Insights (FMI), global needle-free injectors market  are expected to reach US$ 12.3 Bn in 2021, surging at 11.9% CAGR during the forecast period (2021-2031).

Needle-free injection is an innovative drug delivery technology that drives drugs to the skin using force which virtually nullifies the use of hypodermic needle. With growing preference for non-invasive drug delivery system and vaccines, adoption of needle-free injectors is expected to improve over the coming years

Application of needle-free injectors is increasing with rising incidence of diabetes and other chronic diseases across the globe. With increasing number of surgeries, demand for minimally invasive procedures is accelerating the sales of needle-free injectors.

According to Centers for Disease Control and Prevention (CDC), more than 51% of adults in U.S. had at least 1 chronic condition, and 27.2% had multiple chronic conditions in 2018.

Other factors driving the global demand are cost-effectiveness and safety related to needle-free injectors.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13960

Key Takeaways from Needle-free Injectors Market study

• By load type, liquid injections segment will hold around 88.0% of value share globally.
• Based on the technology, spring-loaded jet injector is dominating the market, with over 48.0% of the market share.
• Based on the delivery site, intra dermal injector is expected to hold over 33% of the market share.
• Application of drug delivery will spur the sales of needle-free injectors, with the segment accounting for 65% of the market share.
• Based on the usage, reusable needle free injectors are highly sought-after, contributing over 78% of the market revenue.
• Hospitals are expected to be the primary end-users, holding a market share of 28% during the forecast period.
• By region, North America will dominate the global needle-free injectors market, holding 42% of total market share.
• Europe is expected to be the second-largest market, with Germany spearheading the market growth .
• India will emerge as the most lucrative market across South Asia, accounting for nearly 50% of market share in 2021.
• China will hold leading position in East Asia and is expected to account for nearly 46% of market share.

“Growing prevalence of chronic diseases coupled with rising preference of non-invasive drug delivery system will improve the adoption of needle-free injectors. With rising demand for needle-free injectors, key players are introducing new product launches and are aiming for fast track approvals to capitalize on existing opportunities and sustain their position in the industry “says the FMI Analyst.

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-13960

Who is Winning?

New product launches and approvals, agreements, and collaborations are some of the key growth strategy adopted by the key players. By focusing on these strategies, key players intend to expand their global presence and strengthen their existing product portfolio.

For instance,

• In November 2019, Antares Pharma collaborated with Idorsia for the development of a novel self-administered drug-device product.
• In June 2020, Vitaeris Inc., a biotech company was acquired by CSL Limited. The acquisition was carried out by CSL Limited to achieve the motive of addressing the unmet needs of patients.

The key market players covered by FMI include Pfizer, Inc., Gerresheimer AG, Ferring Pharmaceuticals, CSL Limited (Seqirus UK Limited) and others.

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to a recent report by Future Market Insights, the demand for pelvic floor diagnostics market is expected to rise at a significant pace 6.2% CAGR through the end of the assessment period in 2031

The pelvic floor diagnostics market will witness strong demand owing to the prevalence of associated ailments especially in pregnant women, and increasing awareness levels towards pelvic floor diagnostic testing. The rise in adoption of advanced imaging systems is resulting in superior patient outcomes.

Developed economies such as the U.S. show an increasing trend of adoption of advanced diagnostic devices. Favorable reimbursement scenarios boost market growth. The healthcare and diagnostic infrastructure in the U.S. has advanced at an elevated rate due to increasing research and development activities pertaining to healthcare.

Rising healthcare expenditure, along with growing government support by funding’s and faster approvals has led to the establishment of pelvic floor diagnostic laboratories and a larger number of professionals.

Rising number of grants by private and government players for pelvic floor diagnostics has increased the focus on innovative research solutions for the development of advanced testing systems.

Healthcare standards with advanced diagnostic procedures have gained ground during the last two decades and with the rise in income and the increased investments in research. The pelvic floor diagnostics market has experienced a substantial shift in the adoption of molecular diagnostic devices.

 Key Takeaways from Pelvic Floor Diagnostics Market Study

• Ultrasound systems are expected to reach a revenue share of 37.1% in 2021 with a growing CAGR of 5.7% during forecast period.
• Hospitals will drive sales accounting for over 60% value share through 2031, owing to higher spending capacity.
• Mexico will reflect a 6.1% CAGR through 2031, supported by growing access to superior medical facilities.
• U.K. and France are leading markets in Europe, accounting for over 20% and over 18% of the Europe market respectively in 2021.
• The U.S. is the largest and fastest growing market in North America, exhibiting 5.7% CAGR through the forecast period.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13752

“The growing global geriatric population is prone to pelvic floor disorders. Consequently, advancements diagnostics including imaging and ultrasound systems, coupled with investments in research and academic bodies are set to boost the growth of pelvic floor diagnostics market over the coming decade,” says a Future Market Insights analyst.

Investments in Tech Development to Offer Growth Opportunities

The pelvic floor diagnostics market has emerged as a lucrative area of research in terms of pelvic dysfunction. The development of imaging technology is gaining traction with the rising demand of high-resolution images.

The demand is fueled by increasing awareness among the growing population about the diagnostic options available. Ultrasound systems offer reliable high-resolution imaging. The evolution in the processes involving detection, diagnosis, and treatment of associated diseases is anticipated to cause a demand surge in the pelvic floor diagnostics market.

Who is winning?

Key players in the pelvic floor diagnostics market are focusing on tapping market potential through strategic mergers and acquisitions. This is driven by efficiency in innovative and specialized product portfolios. The market is also set to expand due to increasing activities in research and development to diagnose pelvic floor disorders.

Some of the leading players in the pelvic floor diagnostics market include but are not limited to Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology s.r.o., EndoMed Systems, Richard Wolf, Schölly Fiberoptic, Zhuhai Seesheen Medical Technology, KARL STORZ, Cadwell, The Prometheus Group, Neurosoft, Noraxon USA.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-13752

Segments:

By Product:

• Urodynamics Systems
• Uroflowmetry Devices
• Anal Manometry Systems
• Cystoscopes
• Ultrasound Systems
  • Cart/Trolley Based
  • Portable Bladder Ultrasound Systems
• EMG

By End User:

• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Development Trends

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-13752

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to Future Market Insights (FMI), driven by the rising incidence of respiratory diseases the demand for pulmonology devices market will rise. Respiratory disorders such as asthma, chronic obstructive pulmonary disorder (COPD), and lung cancer is on the rise globally. Smoking and unhealthy living environment are often identified as common causes fuelling the incidence of respiratory disorders.

Government initiatives supported by public and private organizations to spread awareness has led people to focus on early diagnosis of medical conditions to avoid delay in treatment. Furthermore, a number of players are developing new products to expand their product portfolio as well as to maintain their position in the market.

For an instance Olympus has launched a few unique pulmonology devices such as the flexible bronchoscope that has helped the company in maintaining its position in the market. A large number of domestic players are slowly emerging in Asia Pacific. Rise in healthcare expenditure in developing countries and improving reimbursement policies are causing shift in focus among market players from developed to developing countries.

Moreover, the availability of pulmonology devices for healthcare professionals has been impacted by COVID-19 supply chain crisis. However, there are measures taken to manage this situation. Governments have relaxed controls to make supply easy. Export controls have been made easy by several manufacturing countries.

Major manufacturers in the pulmonology devices market are geared up and focusing on local production of pulmonology devices. According to the report, the increasing cases COPD and lung cancer will continue fuelling demand in the market.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-13036

Key Takeaways from pulmonology devices Marker Study

• The demand for pulmonology devices is expected to get higher, enabling the market to exhibit 10.8% CAGR between 2020 and 2030
• Backed by increasing healthcare spending, the U.S. is expected to account for nearly 90% sales in North America
• Favorable reimbursement policies will enable the U.K. to exhibit 13% y-o-y growth in 2021
• Germany and France will showcase increasing investment towards expanding healthcare infrastructure, in turn fuelling the demand for pulmonology devices
• Within East Asia, Japan and South Korea will represent highly attractive markets for sale

Who is Winning?

Leading players in the pulmonology devices market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

• In February 2019, the Conmed Corporation acquired privately-held Buffalo Filter LLC, a leader in surgical smoke evacuation technologies. The company’s comprehensive product portfolio includes smoke evacuation pencils, smoke evacuators, and laparoscopic solutions.
• In November 2019, Cook Medical opened new facility in India. This office enables the company to expand its business in emerging markets.
• In January 2019, the Verathon, Inc launched GlideScope® BFlex, a single-use flexible bronchoscope that offers optimal visibility and maneuverability for routine airway and bronchoscopy procedures.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-13036

Pulmonology devices Market by Category

Product

• Pulmonary Biopsy Devices
  • Single- Use Biopsy Forceps
  • Cytology Brushes
  • Microbiology Brushes
• Endobronchial Ultrasound (EBUS) Needles
  • Endobronchial Ultrasound Fine Biopsy Needles
  • Endobronchial Ultrasound Transbronchial Aspiration Needles
• Airway Stents
  • Silicon Stents
  • Nitinol Stents
  • Stainless Steel Stents
• Airway Extraction Baskets
• Single-Use Bronchoscopes

Indication

• Lung Cancer
• COPD
• Foreign Body Extraction
• Tracheal and Bronchial Stenosis
• Others

End User

• Hospitals
• Pulmonology Clinics
• Ambulatory Surgical Centers

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• MEA

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

3.3. Disease Epidemiology, By Region

3.4. Technology Assessment Vs. Application

3.5. Regulatory Scenario

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-13036

The key market players covered by FMI include Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, Cook Medical Incorporated, Medi-Globe GmbH, Ambu A/S, Verathon, Inc, consolidating their positions through mergers, acquisitions and new product launches.

Valuable Insights into Pulmonology Devices Market

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global pulmonology devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on pulmonology devices market on basis of product in detail cover every aspects of the market such as (pulmonary biopsy devices, endobronchial ultrasound (EBUS) needles, airway stents, airway extraction baskets, single-use bronchoscopes), indication (lung cancer, COPD, foreign body extraction, tracheal and bronchial stenosis and others) and End User (hospitals, pulmonology clinics, ambulatory surgical centers) across seven major regions.

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

According to Future Market Insights (FMI), the global medical nitroglycerin sprays market was valued at US$ 94.4 Mn in 2019, and is expected to register a CAGR of 4.2% during the forecast period, reaching US$ 147.3 Mn by the end of 2030.

Key Takeaways from the Medical Nitroglycerin Sprays Study

• North America touted to retain market hegemony, capturing over two-fifths of the revenue share
• Prophylaxis of angina pectoris to remain the dominant segment, expanding steadily at 4.1% CAGR from 2022-2030
• By distribution channel, online pharmacy sales are poised to witness credible expansion owing to the pandemic and deepening digital literacy
• 90 metered sprays/bottle dose capacity to remain the most preferred option, registering an index of 1.4
• Global medical nitroglycerin sprays market is likely to expand steadily, registering a CAGR of 4.2%

Key Drivers and Restraints of Global Medical Nitroglycerin Spray Market

Medical nitroglycerin is available in multiple dosage forms such as sublingual tables, sprays, in-vitro and patches, and ointments. For instance, nitroglycerin sprays are available in different capacities, ranging between 60 doses per bottle to 230 dose per bottle. Availability of nitroglycerin spray in a wide range of dosage forms and capacities is projected to fuel the global market during the forecast period.

Nitroglycerin spray is inexpensive and hence affordable. It also offers better therapeutic effects as compared to that offered by other medications. Furthermore, it has minimum side-effects as compared to that of conventional drugs. These factors are estimated to drive the nitroglycerin spray market in the next few years.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12620

ccording to the World Health Organization (WHO), cardiovascular disease accounts for nearly 17.9 million deaths every year, which is estimated to contribute to 31% of all global deaths. A rise in the number of people suffering from cardiovascular diseases can be attributed to sedentary lifestyle along with smoking, tobacco & alcohol consumption, and unhealthy diet. Hence, a rise in prevalence of cardiovascular diseases is projected to fuel the global market during the forecast period.

According to the World Health Organization (WHO), the population of people aged 60 years and above is projected to rise from 900 million in 2015 to 2 billion in 2050. Usually, the geriatric population is at high risk of coronary vascular disease. Hence, an increase in the geriatric population is anticipated to boost the global nitroglycerin spray market.

Market segmentation

Medical Nitroglycerin Sprays Market by Application:

• Prophylaxis of Angina Pectoris
• Acute Relief of Attack (Treatment)

Medical Nitroglycerin Sprays Market by Dose Capacity:

• 60 Metered Sprays/Bottles
• 90 Metered Sprays/Bottles
• 200 Metered Sprays/Bottles
• 230 Metered Sprays/Bottles

Medical Nitroglycerin Sprays Market by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Medical Nitroglycerin Sprays Market by Region:

• North America Medical Nitroglycerin Sprays Market
• Latin America Medical Nitroglycerin Sprays Market
• Europe Medical Nitroglycerin Sprays Market
• East Asia Medical Nitroglycerin Sprays Market
• South Asia & Pacific Medical Nitroglycerin Sprays Market
• Middle East & Africa (MEA) Medical Nitroglycerin Sprays Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12620

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Key Inclusion & Exclusion

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Prevalence & Patient Share

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12620

Competitive Intelligence

The global medical nitroglycerin sprays market is highly consolidated, with the presence of four prominent players: Perrigo Company Plc., Evus Health Solutions LLC., G. Pohl-Boskamp GmbH & Co. and Akrimax Pharmaceuticals LLC. These players primarily concentrate on portfolio strengthening by introducing new products into the market.

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global ankylosing spondylitis treatment market will continue to witness steady growth, driven by a slew of myriad, yet interconnected factors. A new report by ESOMAR-certified market research firm, Future Market Insights, offers incisive insights on key factors that will influence growth through 2030.

According to FMI’s report, the options for treatment include disease-modifying anti-rheumatic drugs (methotrexate), nonsteroidal anti-inflammatory drugs (naproxen, ibuprofen, celecoxib, meloxicam, and diclofenac), biologics (certolizumab pegol, secukinumab, infliximab), and biosimilars.

Key Takeaways from Ankylosing Spondylitis Treatment Market Study

• Nonsteroidal anti-inflammatory drugs lead the market as they are looked upon as the first line of treatment for ankylosing spondylitis
• Oral route of administration holds the largest market share due to simplicity of consumption.
• By age group, “adults” contribute to majority of revenue generation as ankylosing spondylitis usually gets initiated in adulthood.
• North America, led by the US, holds the highest market share due to well-established healthcare infrastructure, high incidences of ankylosing spondylitis, and innovations in pharmaceutical industry.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12345

Ankylosing Spondylitis Treatment Market Landscape

The major players in the ankylosing spondylitis market include Wyeth, Mitsubishi Tanabe, Schering-Plough, Takeda, Novartis AG, Amgen, Centocor, Abbott, Eisai, and Pfizer.

As per the Oxford University Press, around 1% of the US population, 1.3-1.56 Mn European population, and 4.63-4.98 Mn population in the Asia Pacific are affected by ankylosing spondylitis. Also, the market is witnessing massive investment on the part of research to table new formulations.

Inorganic growth parameters are also contributing a great deal to the growth of ankylosing spondylitis treatment market. For instance – Novartis AG, in Jan 2019, entered into a collaboration with TrialSpark with an objective of increasing patients’ access to the clinical trials. The enrollment timeline is expected to shorten, thereby speeding up development of novel therapies.

In Oct 2019, the European Commission approved Cosentyx to treat non-radiographic axial spondyloarthritis. The next step includes submission of label update application to US FDA and post approval, the market is expected to grow substantially.

“Agreement” is the other strategy used. For instance – Izana Bioscience, in Dec 2017, entered into a global license agreement with Takeda Pharmaceutical Company for manufacturing, commercializing, and developing Namilumab to treat ankylosing spondylitis.

Also, Zydus Cadila, in Nov 2017, launched Adalimumab’s biosimilar in India. It has been used to treat ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis.

Initiatives like these have been giving impetus to the ankylosing spondylitis market and the status quo is likely to remain the same in the forecast period.

Want More Insights?

The global ankylosing spondylitis treatment market is elaborated on the basis of drug class (Nonsteroidal Anti-inflammatory Drugs, Anti-Inflammatory Drugs, Immunosuppressive Drugs, TNF Blockers, JAK Inhibitors, Steroids, Biologics, and Others), route of administration (parenteral, oral), application (Adults, juvenile), and geography (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA).

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-12345

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Increasing prevalence of eye infections due to ocular surgical procedures is primarily shaping eye infection treatment market. A recent Future Market Insights (FMI) report forecasts that even though the eye infection treatment market would continue to experience a downtrend throughout 2022 due to COVId-19 pandemic, revenues would reach US$ 10 Bn by the end of 2030. Post-operative ocular infections remain among the most common eye infection types, says the FMI study.

Rising Caseloads

Caseloads of ocular surgical conditions such as cataracts, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy are growing due to sedentary lifestyle habits, and expanding geriatric cohort. According to the US statistics 2021, cataracts affect over 24 million Americans aging at least 40 years.

By age 75, about half of the Americans suffer from cataract. Further, diabetic retinopathy affects nearly 7.7 million Americans aging at least 40 years. In similar fashion, there were 48,229 corneal transplants performed in the US in 2015.

Demand for eye infection treatment will continue to receive a strong impetus from increasing awareness about different eye infection types and availability of treatment, further complemented by technological advancements on ophthalmology.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1300

Key Takeaways of Eye Infection Treatment Market Study

• Antibiotics would contribute over 55% revenue share in the eye infection treatment market owing to their use in treating primary eye infections and post-surgical eye infections.
• Eye drop sales capture over 60% market share in the eye infection treatment market.
• Conjunctivitis would account for a third of eye infection treatment demand through 2030.
• Bacterial infections continue to account for over 3/5^th market share.
• Hospitals and retail pharmacies collectively generate over 70% total returns to shareholders.
• Increasing rate of eye surgeries and rising usage of contact lenses continue to push North American market. European market would be upheld by the expanding geriatric pool.

Demand for Eye Infection Drugs to Slump Amidst COVID-19 Pandemic

The coronavirus (COVID-19) pandemic has resulted in widened gap between supply and demand of eye infection treatments. As such, it has significantly reduced ocular surgery rate for short-term basis and, in turn, post-operative eye infections.

According to World Health Organization (WHO), national healthcare resources redirection and utilization to contain COVID-19 pandemic is expected to delay and reschedule the treatment of non-critical healthcare conditions for brief period, including eye care services, and ocular surgeries.

Development and Licensing Deals with Multiple Commercialization Partners

Technology developers are laying greater emphasis on developing of novel ophthalmic formulation technologies and engaging with commercialization partners with licensing-out proprietary ophthalmic technologies.

For instance, Nicox S.A. has licensed out ZERVIATE (cetirizine ophthalmic solution) 0.24% to Eyevance Pharmaceuticals LLC for commercialization of ZERVIATE in the US. ZERVIATE is the first topical ocular formulation of antihistamine cetirizine approved for treatment of ocular itching associated with allergic conjunctivitis. In addition, Ocumension Therapeutics is responsible for all development and commercialization activities in Chinese market for ZERVIATE.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1300

Key Segments:

By Drug Class :

• Antibiotics
  • Sulfonamides
  • Macrolides
  • Erythromycin
  • Chloramphenicol
  • Aminoglycosides
  • Fluoroquinolones
  • Vancomycin
  • Tetracyclines
• Antivirals
  • Thymidine-Based Nucleoside Analogues (Trifluridine)
  • Thymidine Phosphorylase Inhibitors (Trifluridine)
  • Acyclic Nucleoside Analogue of 2’Deoxyguanasine (Ganciclovir)
  • Acyclic Guanine Nucleoside Analog (Acyclovir)
  • Others
• Antifungals
  • Polyenes (Amphotericin B (AMB) And Natamycin (NTM))
  • Azoles (Miconazole (MCZ), Econazole (ECZ) And Ketoconazole (KCZ))
  • Pyrimidines
  • Echinocandins (Caspofungin (CFG) and Micafungin (MFG))
  • Others
• Antihistamines
• Corticosteroids
• Glucocorticoids

By Dosage Form :

• Eye Infections Treatment Tablets
• Eye Infections Treatment Capsules
• Eye Infections Treatment Ophthalmic Ointments
• Eye Infections Treatment Eye Drops
• Others

By Indication :

• Eye Infections Treatment for Conjunctivitis
• Eye Infections Treatment for Keratitis
• Eye Infections Treatment for Endophthalmitis
• Eye Infections Treatment for Blepharitis
• Eye Infections Treatment for Stye or Sty (Hordeolum)
• Eye Infections Treatment for Uveitis
• Eye Infections Treatment for Cellulitis
• Eye Infections Treatment for Ocular Herpes

By Causative Agent :

• Virus
• Bacteria
• Fungus
• Allergens

By Distribution Channels :

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

By Region :

• North America Eye Infections Treatment Market
• Latin America Eye Infections Treatment Market
• Europe Eye Infections Treatment Market
• East Asia Eye Infections Treatment Market
• South Asia & Pacific Eye Infections Treatment Market
• Middle East & Africa (MEA) Eye Infections Treatment Market

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-1300

Know More About FMI’s Eye Infection Treatment Market Study

Eye infection treatment market, a new study from Future Market Insights, opines on eye infections treatment from 2015 – 2021 and presents demand projections from 2022 – 2030 on the basis of; drug class (antibiotics, antivirals, antifungals, antihistamines, corticosteroids, and glucocorticoids), dosage form (tablet, capsule, ophthalmic ointment, and eye drops), indication (conjunctivitis, keratitis, endophthalmitis, blepharitis, stye or sty (hordeolum), uveitis, cellulitis, and ocular herpes), causative agent (virus, bacteria, fungus, and allergens) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and drug stores) across seven prominent regions.

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs